SCHEMBL23747324

SCHEMBL23747324

O=C(NCc1ccc(Cl)cc1)Nc1ccc(CN2CCCCC2=O)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 1/20 0.67
HTR2A P28223 1/20 0.67
MCHR1 Q99705 1/20 0.67
RAB9A P51151 3/20 0.59
POLB P06746 1/20 0.59
NPC1 O15118 1/20 0.59
NAMPT P43490 3/20 0.55
LSS P48449 1/20 0.55
LMNA P02545 1/20 0.54
HPGD P15428 1/20 0.54
TSHR P16473 1/20 0.54
CNR1 P21554 3/20 0.53
ERCC1 P07992 1/20 0.53
ERCC4 Q92889 1/20 0.53
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
WDR91 A4D1P6 1/20 0.51
L3MBTL1 Q9Y468 2/20 0.50
MAPT P10636 2/20 0.50
ALDH1A1 P00352 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23747317 0.98 CHRM1 (0.64) CHRM1HTR2AMCHR1RAB9APOLB
SCHEMBL23747321 0.86 SMN1; SMN2 (0.63) CHRM1HTR2AMCHR1RAB9APOLB
SCHEMBL23747314 0.85 CHRM1 (0.57) CHRM1HTR2AMCHR1RAB9APOLB
SCHEMBL23747527 0.84 F10 (0.57) CHRM1HTR2AMCHR1RAB9APOLB
SCHEMBL23747345 0.84 SMN1; SMN2 (0.66) RAB9APOLBNPC1NAMPTCNR1
SCHEMBL23728037 0.83 CHRM1 (0.55) CHRM1HTR2AMCHR1RAB9APOLB
SCHEMBL23747395 0.82 CHRM1 (0.57) CHRM1HTR2AMCHR1RAB9APOLB
SCHEMBL23747672 0.82 CHRM1 (0.57) CHRM1HTR2AMCHR1RAB9APOLB
SCHEMBL23747458 0.82 CHRM1 (0.57) CHRM1HTR2AMCHR1RAB9APOLB
SCHEMBL23747351 0.81 RAB9A (0.60) CHRM1HTR2AMCHR1RAB9APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230133132-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-05-04 US disclosed
US-20230133132-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-05-04 US disclosed
US-20230133132-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-05-04 US disclosed
WO-2021159015-A1 NAMPT MODULATORS CYTOKINETICS, INC. (US) 2021-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230133132-A1 NAMPT MODULATORS NAMPT, MC4R, SIRT1 CHRM1 1155/4885HTR2A 2115/4885MCHR1 358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.